• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

acute myeloid leukemia (AML) - Articles and news items


Daiichi Sankyo enrols first patient in Phase III acute myeloid leukaemia trial

Industry news / 17 October 2016 / Niamh Louise Marriott, Digital Content Producer

Daiichi Sankyo has enrolled their first patient in the global phase 3 QuANTUM-First study evaluating the oral FLT3-ITD inhibitor quizartinib in patients…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +